November 2011

Abbott Says It Will Split into Two Firms in 2012

Clinical Laboratory Trends / By Robert Michel

FURTHER CHANGES ARE COMING to the in vitro diagnostics (IVD) marketplace. On October 19, Abbott Laboratories, Inc., announced that it would separate into two publicly-traded companies sometime in 2012. One business will be the medical devices and diagnostics business. It will have about $22 billion in annual sales. Of this total, about $4 billion comes from …

Abbott Says It Will Split into Two Firms in 2012 Read More »

To access this post, you must purchase The Dark Report.

At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: Should patients be allowed to see their own lab test results when they are available to their physicians? Kaiser Permanente believes so. Since 2005, Kaiser Permanente has given members real-time access to most laboratory test results in their personal health record (PHR) on www.kp.org. In fact, viewing laboratory test results is the single …

At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients Read More »

To access this post, you must purchase The Dark Report.

Lab Testing, Pathology Is Fast-Growing in China

Pathology Trends / By Robert Michel

CEO SUMMARY: It was record attendance at the major pathology congress which took place in Hangzhou, China, last month. Because of the ongoing growth of China’s economy, the demand for healthcare—and for high-quality clinical lab and pathology testing—is rising at an accelerated pace. During his visit to the pathology congress and Chinese hospital labs, your …

Lab Testing, Pathology Is Fast-Growing in China Read More »

To access this post, you must purchase The Dark Report.

November 7, 2011 “Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

Many experts were impressed when General Electric Co. ponied up $587 million to acquire pathology testing company Clarient, Inc., in October 2010. Now comes further insight behind this transaction. At an investment conference in Boston on November 3, John Dineen, CEO of GE Healthcare, told the audience that his company—currently generating revenue of $2.4 billion …

November 7, 2011 “Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.